FdaApplication
NDA 205422
Identifiers
- fda_app_no: NDA205422
Properties
| Property | Value |
|---|---|
| applicant_name | OTSUKA PHARMACEUTICAL CO LTD |
| application_type | NDA |
| approval_date | 2015-07-10 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REXULTI | BREXPIPRAZOLE | 4MG | TABLET;ORAL |
| REXULTI | BREXPIPRAZOLE | 0.25MG | TABLET;ORAL |
| REXULTI | BREXPIPRAZOLE | 0.5MG | TABLET;ORAL |
| REXULTI | BREXPIPRAZOLE | 3MG | TABLET;ORAL |
| REXULTI | BREXPIPRAZOLE | 1MG | TABLET;ORAL |
| REXULTI | BREXPIPRAZOLE | 2MG | TABLET;ORAL |
6 products